docetaxel anhydrous has been researched along with Cognition Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crumbaker, M; Gurney, H | 1 |
| Chung, SK; Dong, CM; Ho, LC; Huang, YH; Lai, CSW; Li, Q; Sham, PC; Shi, DD; Wang, XM; Wu, EX; Zhang, ZJ | 1 |
| Chai, JW; Chen, VC; Lin, TY; Weng, JC; Yeh, DC | 1 |
| Allen, C; De Souza, R; Fardell, JE; Henderson, J; Johnston, I; Piquette-Miller, M; Vardy, J; Zhang, J | 1 |
| Aotani, E; Gemma, A; Hamano, T; Kobayashi, K; Takebayashi, T; Takeuchi, M | 1 |
| Ahmad Kiadaliri, A; Bastani, P | 1 |
1 review(s) available for docetaxel anhydrous and Cognition Disorders
| Article | Year |
|---|---|
Dose considerations for anti-cancer drugs in metastatic prostate cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cognition Disorders; Docetaxel; Dose-Response Relationship, Drug; Fatigue; Humans; Male; Precision Medicine; Prostatic Neoplasms, Castration-Resistant; Taxoids | 2017 |
1 trial(s) available for docetaxel anhydrous and Cognition Disorders
| Article | Year |
|---|---|
Identification of adverse events that have a negative impact on quality of life in a clinical trial comparing docetaxel versus S-1 with cisplatin in lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cognition Disorders; Docetaxel; Drug Combinations; Gastrointestinal Diseases; Humans; Lung Neoplasms; Oxonic Acid; Quality of Life; Taxoids; Tegafur | 2016 |
4 other study(ies) available for docetaxel anhydrous and Cognition Disorders
| Article | Year |
|---|---|
Chemotherapy-Induced Cognitive Impairment Is Associated with Cytokine Dysregulation and Disruptions in Neuroplasticity.
Topics: Animals; Antineoplastic Agents; Cognition; Cognition Disorders; Cyclophosphamide; Cytokines; Dendritic Spines; Disease Models, Animal; Docetaxel; Doxorubicin; Hippocampus; Magnetic Resonance Imaging; Maze Learning; Mice; Neuronal Plasticity; Neurons | 2019 |
Predicting chemo-brain in breast cancer survivors using multiple MRI features and machine-learning.
Topics: Adult; Algorithms; Anisotropy; Antineoplastic Agents; Brain; Brain Mapping; Breast Neoplasms; Cancer Survivors; Case-Control Studies; Cognition Disorders; Docetaxel; Epirubicin; Female; Fourier Analysis; Humans; Machine Learning; Magnetic Resonance Imaging; Middle Aged; Regression Analysis; Young Adult | 2019 |
The impact of sustained and intermittent docetaxel chemotherapy regimens on cognition and neural morphology in healthy mice.
Topics: Animals; Antineoplastic Agents; Astrocytes; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; Behavior, Animal; Body Weight; Brain; Cognition; Cognition Disorders; Delayed-Action Preparations; Docetaxel; Drug Administration Schedule; Male; Mice; Taxoids | 2014 |
Health-related quality of life after chemotherapy cycle in breast cancer in Iran.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cognition Disorders; Cohort Studies; Cyclophosphamide; Docetaxel; Double-Blind Method; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Health Status; Humans; Iran; Middle Aged; Nausea; Quality of Life; Taxoids | 2011 |